FDA Adverse Event Injury Summary report: N

INTRALASE FS2

MDR report key: 7239153 · Received February 2, 2018

Report

Report Number
3006695864-2018-00197
Event Type
Injury
Date Received
February 2, 2018
Date of Event
January 6, 2018
Report Date
March 7, 2018
Manufacturer
ABBOTT MEDICAL OPTICS
Product Code
HNO
UDI-DI
05050474573451
PMA / PMN Number
K060372
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
PA, US
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

ALL PERTINENT INFORMATION AVAILABLE TO ABBOTT MEDICAL OPTICS HAS BEEN SUBMITTED.

Additional Manufacturer Narrative · 1

A RECORD REVIEW WAS PERFORMED. A PRODUCT DEFICIENCY REVIEW WAS PERFORMED AND THERE IS NO PRODUCT DEFICIENCY IDENTIFIED. A DOCUMENT, SERVICE HISTORY, AND TRENDING WAS REVIEWED. THERE IS NOT A RECOGNIZABLE ADVERSE TREND. THE RISKS AND MITIGATIONS ASSOCIATED WITH THE COMPLAINT ISSUE ARE IDENTIFIED IN EXISTING RISK DOCUMENTS AND NO NEW RISKS WERE IDENTIFIED AS PART OF THIS INVESTIGATION. A LABELING REVIEW WAS CONDUCTED; THE OPERATOR MANUAL FOR THE SYSTEM WAS REVIEWED AND FOUND TO INCLUDE ADEQUATE INSTRUCTIONS FOR USE, WARNINGS AND OPERATIONAL ERRORS. ALL PERTINENT INFORMATION AVAILABLE TO JOHNSON & JOHNSON SURGICAL VISION, INC. HAS BEEN SUBMITTED.

Description of Event or Problem · 1

THE SURGERY CENTER REPORTED THAT A LASER VISION CORRECTION PATIENT PRESENTED WITH DIFFUSE LAMELLAR KERATITIS (DLK) STAGE 3+ ON BOTH EYES (OU) AT 1-DAY POST-OPERATIVE EXAM. ORAL STEROIDS (PRED FORTE) WERE PRESCRIBED AND TOPICAL STEROID DOSAGE WAS INCREASED TO RESOLVE SYMPTOMS. BEST CORRECTED VISUAL ACUITY (BCVA) FROM (B)(6) 2017: RIGHT EYE PRE-OP 20/20 -4.00 X -1.50 X 170, LEFT EYE PRE-OP 20/20 -3.75 X -1.25 X 10. UNCORRECTED VISUAL ACUITY (UCVA) FROM (B)(6) 2018: RIGHT EYE POST-OP 20/20, LEFT EYE POST-OP 20/20. THIS REPORT IS FOR THE FEMTO LASER. A SEPARATE REPORT WILL BE SUBMITTED FOR THE EXCIMER LASER.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
79189 INTRALASE FS2 FEMTOSECOND LASER HNO ABBOTT MEDICAL OPTICS 20005D 05050474573451

Patients

Seq Age Sex Outcome Treatment
1 23 YR Required Intervention